About Mabtech AB

Mabtech AB is a privately owned Swedish biotech company founded in 1986. Mabtech develops, manufactures and markets high quality monoclonal antibodies and kits suited for ELISA, ELISpot and FluoroSpot. For many years we have been a world leader in the field of ELISpot due to our strong research focus and continuous effort to optimize this technique. Our close collaborations with both academia and industry around the globe pave the way for future developments that help the research community achieve results.

website icon
Website
employees icon
Employees
industry icon
Industry
Research Services
location icon
Headquarter
Augustendalstorget 9, Nacka Strand, Stockholm County 131 52, SE
description icon
Founded
1986
description icon
Keywords
Elisa, Reader, Immunoassays, Elispot, Fluorospot, Monoclonal Antibodies, Csl, Spot Analysis

Frequently Asked Questions about Mabtech AB

Who is the CEO of Mabtech AB?

Kjell Ostrand is the CEO of Mabtech AB. To contact Kjell Ostrand email at [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more